Review at baseline showed two wounds with size 10 cm x 3 cm and 12 cm x 4 cm, respectively both with a depth of 1 cm. The majority of the wound areas were granulated (90%) and there was slough present (10%) but no necrotic tissue. Exudate levels were low and clear/serous in appearance.
12 days after the first visit the wounds had progressed negatively and 80% of the wounds were now epithelialized and 20% still granulated. Levels of exudate in the canister
were low, however the exudate levels around the wounds were medium and brown/bloody as well as viscous in appearance.
At follow up visit 3 (30 days) the wound on the ankle had decreased to 0,4 cm x 1 cm with a depth of 0.2 cm with 90% of the surface epithelialized and 10% granulated while the second wound was now fully healed.
The exudate was still appearing brown/bloody and viscous and moderate in amount.
44 days (88 days after the trauma) after first visit both wounds were fully healed.
There was no signs of infection in any of the wounds during the treatment duration and no antibiotics were administered.
The periwound skin appeared continuously healthy the whole period and no wound filler was used.
No additional dressing changes outside of the planned follow-up visits.
Sharp debridement was performed at each follow up visit except visit 4 (44 days after baseline)
The patient reported no pain before or during dressing removal.
All performance aspects of the device was perceived as ‘Very good’ including suitability of size and shape of the dressing. The dressing size of 15x30 cm formed well on the tibia and covered both skin grafts.
The exudate management ability of the device was good and worked very satisfactory despite one dressing covering a two-wound situation.
The overall impression was very good as the skin graft had improved quickly in the follow-up of a complicated trauma wound followed by revision and skin grafting, and the device had been easy and effortless to use.